IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.
- DOI
- 10.1038/s41467-026-73974-5
- Published
- 2026 Jun 17
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-73974-5,
title = {IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.},
author = {Panagioti E and Kelley HJ and Ling AL and Sejour L and Saini S and Goins WF and Roberts D and Sotiriou S and Bryan Iorgulescu J and Dixon KO and Yaffe MB and Vlachos IS and Castro MG and Lawler SE and Freeman GJ and Kuchroo VK and Antonio Chiocca E and Cook CH},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-73974-5},
url = {https://doi.org/10.1038/s41467-026-73974-5}
}RIS
TY - JOUR TI - IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma. AU - Panagioti E AU - Kelley HJ AU - Ling AL AU - Sejour L AU - Saini S AU - Goins WF AU - Roberts D AU - Sotiriou S AU - Bryan Iorgulescu J AU - Dixon KO AU - Yaffe MB AU - Vlachos IS AU - Castro MG AU - Lawler SE AU - Freeman GJ AU - Kuchroo VK AU - Antonio Chiocca E AU - Cook CH PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-73974-5 UR - https://doi.org/10.1038/s41467-026-73974-5 ER -
APA
E, P., HJ, K., AL, L., L, S., S, S., WF, G., D, R., S, S., J, B. I., KO, D., MB, Y., IS, V., MG, C., SE, L., GJ, F., VK, K., E, A. C., & CH, C. (2026). IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.. Nature communications. https://doi.org/10.1038/s41467-026-73974-5
Source records
- pubmed · retrieved 2026-09-26T07:58:39.116Z